Publication Type : Journal Article
Source : Diabetes Metab Syndr Clin Res Rev. 2023 Jan 1;17(1).
Url : https://pubmed.ncbi.nlm.nih.gov/36563492/
Campus : Kochi
School : School of Medicine
Year : 2023
Abstract :
Background and aims: In this study, we aimed to refer eligible (patients with stable blood sugar and without any history of cardiovascular events or proliferative retinopathy) and willing persons with diabetes (PwDs) to primary healthcare centers (PHCs) from tertiary care and to compare the care indicators.
Methods: This before-after interventional study was conducted among PwDs aged ≥18 years at a tertiary care hospital in South India. Care indicators (regularity to the clinic, waiting time, and blood sugar control status) were assessed before down referral and after three months of follow-ups at PHCs.
Results: Of 204 PwDs referred to PHCs. Among them, 88% (n = 180) registered at PHCs for care and 46% (n = 94, 95% CI 39.1-53.2%) were lost to follow-ups at PHCs. The main reason for loss to follow-ups was the unavailability of medicines at PHCs(n = 41, 44%). Among those who were on regular follow-ups at PHCs, there was no significant difference in fasting blood glucose (FBG) control status compared to tertiary (52%-64.6%, p = 0.083). However, there was a significant improvement in the regularity of clinic visits (75% vs. 100%, p < 0.001), consultation waiting time (90 vs. 60 min, p = 0.028), and waiting time at pharmacy queues (120 vs. 30 min, p < 0.001) between tertiary care and PHCs. However, among those registered at PHCs, only 40.6% (n = 73, 95% CI 33.3-48.1) were willing to continue care at PHCs for their diabetes management.
Conclusion: Primary care was better than tertiary care in terms of PwD's regularity of clinic visits and waiting time for care.
Cite this Research Publication : Olickal JJ, Chinnakali P, Suryanarayana BS, Rajanarayanan S, Vivekanandhan T, Saya GK, et al. Down referral and assessing comprehensive diabetes care in primary care settings: An operational research from India. Diabetes Metab Syndr Clin Res Rev. 2023 Jan 1;17(1).